C5AR1 and colorectal carcinoma: Together, our study, specifically focusing on the implication of complement in colorectal tumorigenesis, revealed that C5aR1 is a master regulator with pleiotropic effects that initiates CRC by modulating a tumor-promoting immune response; thus, C5aR1 may exert as a promising potential target for CRC prevention (Figure 6).